AdvaMed
Feb 04, 2012
Among stories in this edition of "This Week in Devices," EMDT's Norbert Sparrow covers further developments in l'affaire Pip—the recent breast...
Nov 29, 2011
Consistent with what one would expect as the 2012 election season barrels ahead, AdvaMed is directing ever more money toward political lobbying efforts....
Oct 14, 2011
John Dalli, European commissioner for health and consumer policy, recently gave a speech at the Eucomed MedTech Forum 2011 in which he enumerated a number of...
Sep 28, 2011
By Joe Rotino, VP of Quality and Regulatory Affairs at Pro-Dex An important quote that came out of the AdvaMed panel, “Impact of 510(k) Review Process...
Sep 28, 2011
By Tricia Rodewald “Uncertainty” is a main theme coming out of this year’s AdvaMed convention.   Uncertainty about 510(k) process...
Sep 28, 2011
By Tricia Rodewald  The key to improving relations between FDA and industry is to focus on pragmatism rather than mutual criticism. You would...
Sep 28, 2011
By Tricia Rodewald Innovation is alive and well at this year’s AdvaMed conference. While it’s clear that medical device innovation in the United...
Sep 26, 2011
By Tricia Rodewald To say that there’ve been sleepless nights over healthcare reform, also known as the Affordable Care Act of 2010, would probably be...
Sep 26, 2011
AdvaMed chairman James Mazzo (left) and AdvaMed CEO Stephen J. Ubl are working to secure the U.S.'s medtech leadership role.  At AdvaMed 2011,...
Sep 20, 2011
New content posted to www.mddionline.com includes a blog on new legislation that would make the R&D tax credit permanent, a chat with Matt Jennings of...